SACHIDANAND KAMTAM: Open Payments
NPI 1649318494 · EXTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 28 payments from 12 companies in 2025. Trend: 2023 $21 · 2024 $1,653 · 2025 $577
Food & beverage: $577
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $98 |
| Janssen Pharmaceuticals, Inc | 4 | $91 |
| Neurocrine BioSciences, Inc. | 3 | $68 |
| Teva Pharmaceuticals USA, Inc. | 3 | $64 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Collegium Pharmaceutical, Inc. | 3 | $47 |
| Alkermes, Inc. | 2 | $38 |
| Lundbeck LLC | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
Products named: SPRAVATO, REXULTI, INGREZZA, COBENFY, Jornay PM, UZEDY, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across PA — which companies pay providers there.
